St. Jude study shows survivors of acute lymphoblastic leukemia are increasingly likely to develop second tumors during adulthood, demonstrating the value of long-term patient follow-up in designing safer treatments

Survivors of acute lymphoblastic leukemia have a significantly increased risk of secondary cancers developing over 30 years after leukemia treatment when compared to the general population, according to a study in the March 21 issue of JAMA.